Key result
The iHEART study is a randomized controlled trial protocol designed to evaluate whether a mobile health ECG intervention improves the detection of recurrent atrial fibrillation compared to usual care.
Why the study?
Does a mobile health ECG intervention improve the detection of recurrent atrial fibrillation in patients with a recent history of atrial fibrillation?
Population
300 participants with a recent history of atrial fibrillation
Comparison
iHEART intervention for 6 months vs Usual cardiac care for 6 months
Design
Other, 1:1
Follow-up
6 months
Authors
Loading...
May support real-world AF detection via mHealth; hypothesis-generating for self-management, requires RCTs before practice change.
RCT (n=300)
Single-blind (outcome assessors)
1:1 block allocation, stratified by age and gender
No
Does a mobile health ECG intervention improve the detection of recurrent atrial fibrillation in patients with a recent history of atrial fibrillation?
This study protocol outlines a randomized controlled trial to evaluate whether a mobile health ECG and text messaging intervention improves the detection and management of recurrent atrial fibrillation compared to usual care.
Hickey et al. (2016) conducted an RCT in Atrial fibrillation (n=300). iHEART intervention (AliveCor Mobile ECG and motivational text messages) vs. Usual cardiac care was evaluated on Detection of recurrence of atrial fibrillation. The iHEART study is a randomized controlled trial protocol designed to evaluate whether a mobile health ECG intervention improves the detection of recurrent atrial fibrillation compared to usual care.